Literature DB >> 9355128

Pre-erythrocytic-stage immune effector mechanisms in Plasmodium spp. infections.

D L Doolan1, S L Hoffman.   

Abstract

The potent protective immunity against malaria induced by immunization of mice and humans with radiation-attenuated Plasmodium spp. sporozoites is thought to be mediated primarily by T-cell responses directed against infected hepatocytes. This has led to considerable efforts to develop subunit vaccines that duplicate this protective immunity, but a universally effective vaccine is still not available and in vitro correlates of protective immunity have not been established. Contributing to this delay has been a lack of understanding of the mechanisms responsible for the protection. There are now data indicating that CD8+ T cells, CD4+ T cells, cytokines, and nitric oxide can all mediate the elimination of infected hepatocytes in vitro and in vivo. By dissecting the protection induced by immunization with irradiated sporozoite, DNA and synthetic peptide-adjuvant vaccines, we have demonstrated that different T-cell-dependent immune responses mediate protective immunity in the same inbred strain of mouse, depending on the method of immunization. Furthermore, the mechanism of protection induced by a single method of immunization may vary among different strains of mice. These data have important implications for the development of pre-erythrocytic-stage vaccines designed to protect a heterogeneous human population, and of assays that predict protective immunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9355128      PMCID: PMC1692030          DOI: 10.1098/rstb.1997.0121

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  65 in total

1.  Inhibitory activity of interferons and interleukin 1 on the development of Plasmodium falciparum in human hepatocyte cultures.

Authors:  S Mellouk; R K Maheshwari; A Rhodes-Feuillette; R L Beaudoin; N Berbiguier; H Matile; F Miltgen; I Landau; S Pied; J P Chigot
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

2.  Immunity to sporozoite-induced malaria infeciton in mice. I. The effect of immunization of T and B cell-deficient mice.

Authors:  D H Chen; R E Tigelaar; F I Weinbaum
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

3.  Interleukin 12 induction of interferon gamma-dependent protection against malaria.

Authors:  M Sedegah; F Finkelman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

4.  Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.

Authors:  P Romero; J L Maryanski; G Corradin; R S Nussenzweig; V Nussenzweig; F Zavala
Journal:  Nature       Date:  1989-09-28       Impact factor: 49.962

5.  Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.

Authors:  S Li; M Rodrigues; D Rodriguez; J R Rodriguez; M Esteban; P Palese; R S Nussenzweig; F Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro.

Authors:  D Mazier; S Mellouk; R L Beaudoin; B Texier; P Druilhe; W Hockmeyer; J Trosper; C Paul; Y Charoenvit; J Young
Journal:  Science       Date:  1986-01-10       Impact factor: 47.728

7.  TNF inhibits malaria hepatic stages in vitro via synthesis of IL-6.

Authors:  A Nussler; S Pied; J Goma; L Rénia; F Miltgen; G E Grau; D Mazier
Journal:  Int Immunol       Date:  1991-04       Impact factor: 4.823

8.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

9.  Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

Authors:  S Khusmith; M Sedegah; S L Hoffman
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells.

Authors:  A Aggarwal; S Kumar; R Jaffe; D Hone; M Gross; J Sadoff
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 2.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

3.  Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.

Authors:  Ann M Moormann; Peter Odada Sumba; Daniel J Tisch; Paula Embury; Charles H King; James W Kazura; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2009-09       Impact factor: 2.345

4.  Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.

Authors:  William O Rogers; Walter R Weiss; Anita Kumar; João C Aguiar; John A Tine; Robert Gwadz; Joseph G Harre; Kalpana Gowda; Dharmendar Rathore; Sanjai Kumar; Stephen L Hoffman
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.

Authors:  M Sedegah; T R Jones; M Kaur; R Hedstrom; P Hobart; J A Tine; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

6.  Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naïve and malaria-exposed individuals.

Authors:  Philip Bejon; Sheila Keating; Jedidah Mwacharo; Oscar K Kai; Susanna Dunachie; Michael Walther; Tamara Berthoud; Trudie Lang; Judy Epstein; Daniel Carucci; Philippe Moris; Joe Cohen; Sarah C Gilbert; Norbert Peshu; Kevin Marsh; Adrian V S Hill
Journal:  Infect Immun       Date:  2006-09-11       Impact factor: 3.441

Review 7.  Vaccines against malaria.

Authors:  Adrian V S Hill
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-12       Impact factor: 6.237

8.  Proteogenomic analysis of the total and surface-exposed proteomes of Plasmodium vivax salivary gland sporozoites.

Authors:  Kristian E Swearingen; Scott E Lindner; Erika L Flannery; Ashley M Vaughan; Robert D Morrison; Rapatbhorn Patrapuvich; Cristian Koepfli; Ivo Muller; Aaron Jex; Robert L Moritz; Stefan H I Kappe; Jetsumon Sattabongkot; Sebastian A Mikolajczak
Journal:  PLoS Negl Trop Dis       Date:  2017-07-31

9.  The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum.

Authors:  Michael T White; Jamie T Griffin; Azra C Ghani
Journal:  Malar J       Date:  2013-08-08       Impact factor: 2.979

10.  Quantitative PCR evaluation of cellular immune responses in Kenyan children vaccinated with a candidate malaria vaccine.

Authors:  Jedidah Mwacharo; Susanna J Dunachie; Oscar Kai; Adrian V S Hill; Philip Bejon; Helen A Fletcher
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.